Abiopharma

Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F »)

Securities Fraud Investigation Into Medpace Holdings, Inc. (MEDP) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

VINCI COMPASS TO ANNOUNCE FIRST QUARTER 2026 RESULTS AND HOST CONFERENCE CALL AFTER MARKET CLOSE ON MONDAY, MAY 11, 2026

Pure Cycle Announces Financial Results For the Three and Six Months Ended February 28, 2026

ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F

ADOBE, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Adobe, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADBE

Hudbay to Host Conference Call for First Quarter 2026 Results